Tag: biotechnology

117

FRAMINGHAM, Mass., June 15, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of liquid, gel ...

NWBio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for Glioblastoma Brain Cancer

142

Median survival of top 100 patients is 40.5 months,Median survival of all 331 patients is 23.1 months, Longest survivors have ...

LexaGene Enters Collaboration to Incorporate Cancer Sequencing Technology into a New Product

122

BEVERLY, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for ...

Q BioMed Inc. Prices $5.5 Million Public Offering

110

Proceeds To Fund Commercialization of First Approved Drug and Pivotal Clinical Programs in 2018 NEW YORK, January 30, 2018 /PRNewswire/ -- ...

GT Biopharma Announces $7.1 Million Convertible Debt Financing

107

LOS ANGELES, January 23, 2018 /PRNewswire/ -- GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) today announced that it has entered ...

Earth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD Patents

by Drew Hendricks

107

Aug 01, 2017, ETST, OTC Disclosure & News Service - Hollywood, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Earth Science ...

CytoDyn Injects First Patient in Its Current Phase 3 Study

CytoDyn Treats First Patient with PRO 140 in Phase 2 Trial for Graft versus Host Disease

105

VANCOUVER, Washington, May 17, 2017, CYDY, (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of ...

Cocrystal Pharma Receives Investment Through Private Placement

by Anthony Ramsumiran

107

BOTHELL, WA and ATLANTA, GA--(Marketwired - Apr 24, 2017) - On April 20, 2017, Cocrystal Pharma, Inc. (OTCQB: COCP) (the ...

Immune Therapeutics Clears Critical Regulatory Hurdle for Lodonal in Kenya

by Drew Hendricks

102

ORLANDO, Fla., March 17, 2017, IMUN, (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for ...

ProtoKinetix Announces Start of Phase 1 & Phase 2 Clinical Trials for the use of AAGP™ PKX-001 Treated Islet Cells in the Treatment of Type 1 Diabetes

108

St. Marys, West Virginia, March 9, 2017, PKTX ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix") (www.protokinetix.com) today announced the ...

ETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.

102

Hollywood, March 06, 2017, ETST, (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an ...

CTD Holdings Closes on $2 Million Private Placement

CTD Holdings Closes $2 Million Private Placement

106

ALACHUA, FL-- CTDH, (Marketwired - February 23, 2017) - CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that ...

Earth Science Tech, Inc. Enters $60B Pet Industry with its Nutraceutical Scientific High Grade Hemp CBD Oil Intended for Domestic Animals

102

Hollywood, Feb. 16, 2017, ETST,(GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative ...

ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration

104

ST. MARYS, W. Va.--PKTX, (BUSINESS WIRE)-- ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix") (www.protokinetix.com) updates its stockholders on the ...

CytoDyn Files for Breakthrough Therapy Designation With the FDA for PRO 140 in HIV Therapy

104

VANCOUVER, Washington, Jan. 11, 2017, CYDY, (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of ...

Rasna Therapeutics, Inc. Closes Private Placement of $2 Million

105

Dec 27, 2016, RASP OTC Disclosure & News Service - Rasna Therapeutics, Inc. (OTCQB:RASP), a development stage biotechnology company focused ...

Actinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical Programs

103

- Dr. Larrieux brings significant experience managing analytical development quality control of immunotherapies to treat cancer and small molecule therapies ...

PharmaCyte Biotech to Conduct Pancreatic Cancer Clinical Trial in United States

PharmaCyte Biotech Granted FDA Pre-IND Meeting for Pancreatic Cancer Therapy

131

LAGUNA HILLS, Calif., Nov. 29, 2016, PMCB, (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused ...

CytoDyn Announces $10.0 Million Registered Direct Offering